Internal Medicine, Cardiovascular Disease · Blue Bell, PA
NPI
1265437073
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
510 Township Line Rd Ste 140
Blue Bell, PA, 19422
Phone (610) 279-7696
Groups this clinician bills Medicare through
Medicare paid, 2024
$445K
3,847 services
Medicare patients, 2024
805
Average age 76
Drug cost, 2024
$718K
5,150 prescriptions
Company payments, 2025
$184
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Albert Janke was code 93000 (electrocardiogram), 712 times for 348 patients. In total Albert Janke billed 3,847 services in 48 codes, and Medicare paid $445K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 712 | 348 | $11.28 | $8,033 |
| 99214 Office E&M - Established | Office | 662 | 333 | $96.19 | $64K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 569 | 319 | $13.33 | $7,585 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 348 | 87 | $2.40 | $837 |
| 99232 Hospital E&M - Subsequent | Facility | 242 | 144 | $68.44 | $17K |
| 93306 Echocardiography (TTE/TEE) | Facility | 116 | 114 | $58.54 | $6,790 |
| 93015 Electrocardiogram | Office | 105 | 105 | $60.96 | $6,401 |
| 99223 Hospital E&M - Initial | Facility | 98 | 95 | $150.53 | $15K |
| 93306 Echocardiography (TTE/TEE) | Office | 96 | 95 | $150.28 | $14K |
| 78431 Myocardial Perfusion Scan | Office | 76 | 76 | $2,110.64 | $160K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 76 | 76 | $646.02 | $49K |
| 93296 External Electrocardiographic Monitoring | Office | 72 | 22 | $17.88 | $1,287 |
| 99233 Hospital E&M - Subsequent | Facility | 71 | 50 | $102.82 | $7,300 |
| 93010 Electrocardiogram | Facility | 67 | 42 | $6.95 | $466 |
| 78434 Myocardial Perfusion Scan | Office | 61 | 61 | $616.93 | $38K |
By year: 2022 $328K for 4,357 services; 2023 $339K for 3,436 services; 2024 $445K for 3,847 services.
Medicare prescription drug claims, 2024
In 2024, the drug Albert Janke prescribed most often to Medicare patients was Metoprolol Succinate, with 752 prescriptions and refills. In total Albert Janke wrote 5,150 Medicare prescriptions that cost $718K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 752 | 2,056 | 233 | $14K |
| Rosuvastatin Calcium Generic | 682 | 1,967 | 215 | $11K |
| Atorvastatin Calcium Generic | 441 | 1,173 | 124 | $6,582 |
| Eliquis Apixaban | 304 | 650 | 75 | $375K |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 264 | 755 | 85 | $17K |
| Valsartan Generic | 256 | 735 | 86 | $12K |
| Amlodipine Besylate Generic | 225 | 629 | 71 | $1,437 |
| Clopidogrel Clopidogrel Bisulfate | 214 | 593 | 61 | $3,202 |
| Lisinopril Generic | 170 | 452 | 51 | $1,487 |
| Furosemide Generic | 143 | 380 | 56 | $709 |
| Carvedilol Generic | 103 | 284 | 34 | $1,528 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 100 | 260 | 28 | $3,619 |
| Losartan Potassium Generic | 84 | 238 | 28 | $787 |
| Ezetimibe Generic | 68 | 190 | 24 | $1,740 |
| Nifedipine Er Nifedipine | 49 | 147 | 18 | $2,531 |
Brand drugs: 599 claims; generic drugs: 4,551 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Albert Janke $184 ($184 in general payments such as food, travel and fees) from 5 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $60.35.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.